UPDATE 1-Hikma profit jumps on strong injectible drugs sales
March 11, 2015 at 03:53 AM EDT
March 11 (Reuters) - Hikma Pharmaceuticals Plc reported a 21 percent rise in full-year pretax profit, helped by a stronger-than-expected performance at its high-margin injectible drugs business.
